Information  X 
Enter a valid email address

Beximco Pharma Ltd GDR (BXP)

Date Time Source Announcement
28 Apr 2022 7:00 am
RNS
Q3 Financial Results
01 Apr 2022 7:00 am
RNS
Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC
17 Mar 2022 2:30 pm
RNS
MPP sub-license for Pfizer's COVID-19 treatment
28 Jan 2022 7:00 am
RNS
Half Year Results 2021-22
21 Jan 2022 7:00 am
RNS
Payment of Cash Dividend
20 Jan 2022 9:00 am
RNS
License to produce molnupiravir for COVID-19
30 Dec 2021 10:38 am
RNS
World's first generic version of Pfizer's Paxlovid
24 Dec 2021 7:00 am
RNS
Annual General Meeting Statement
08 Dec 2021 7:00 am
RNS
Delivery of COVID-19 vaccine doses
02 Dec 2021 7:00 am
RNS
Update on the supply of COVID-19 vaccine
24 Nov 2021 7:43 am
RNS
Statement re: media comment
16 Nov 2021 7:00 am
RNS
Notice of AGM
11 Nov 2021 10:30 am
RNS
Results for First Quarter Ended 30 September 2021
09 Nov 2021 7:00 am
RNS
Launch of world's first generic molnupiravir
02 Nov 2021 7:00 am
RNS
Results for the year ended 30 June 2021
21 Oct 2021 12:36 pm
RNS
Notification of Preliminary Results and AGM
11 Oct 2021 7:00 am
RNS
Update on the supply of COVID-19 vaccine
01 Oct 2021 7:00 am
RNS
Completion of Sanofi Bangladesh Acquisition
14 Sep 2021 10:20 am
RNS
Sanofi Bangladesh Share Purchase Agreement signed
03 Sep 2021 1:10 pm
RNS
Acquisition Approved by Bangladesh Bank
25 Aug 2021 6:01 pm
RNS
Statement re: media comment
26 Jul 2021 7:00 am
RNS
FDA approval for muscle relaxant drug Baclofen
07 Jul 2021 2:23 pm
RNS
Update on the supply of COVID-19 vaccine
30 Apr 2021 7:00 am
RNS
Q3 Financial Results
28 Apr 2021 7:00 am
RNS
Update on the supply of COVID-19 vaccine
24 Mar 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
04 Feb 2021 7:34 am
RNS
Update on the supply of COVID-19 vaccine
28 Jan 2021 7:00 am
RNS
Half Year Results 2020-21
22 Jan 2021 7:00 am
RNS
Payment of Cash Dividend
21 Jan 2021 9:34 am
RNS
Proposed acquisition of stake in Sanofi Bangladesh
18 Jan 2021 7:00 am
RNS
Board Changes
14 Jan 2021 9:00 am
RNS
Update on the supply of COVID-19 vaccine
11 Jan 2021 7:00 am
RNS
Stock Dividend Issued
  7:00 am
RNS
Confirmation of Board Changes
21 Dec 2020 7:00 am
RNS
AGM Statement
02 Dec 2020 11:01 am
RNS
Board Changes
23 Nov 2020 7:00 am
RNS
Notice of AGM
16 Nov 2020 7:00 am
RNS
Results for First Quarter Ended 30 September 2020
13 Nov 2020 7:00 am
RNS
Results for First Quarter Ended 30 September 2020
11 Nov 2020 7:00 am
RNS
Results for the year ended 30 June 2020
05 Nov 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:40 pm
RNS
MOU with SII and GOB for COVID-19 vaccine
29 Oct 2020 7:00 am
RNS
Notification of Preliminary Results and AGM
21 Sep 2020 7:00 am
RNS
Beximco Pharma receives eighth FDA approval
28 Aug 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  8:31 am
RNS
Beximco and SII to cooperate on a COVID-19 vaccine
30 Jul 2020 7:00 am
RNS
Board Change
23 Jun 2020 7:00 am
RNS
Q3 Financial Results and Business Update
21 May 2020 7:00 am
RNS
World's first generic remdesivir for COVID-19
04 May 2020 7:00 am
RNS
COVID-19 Update
30 Mar 2020 7:00 am
RNS
Beximco donates PPE to healthcare professionals
24 Feb 2020 7:00 am
RNS
Beximco announces Commercial Agreement with Mylan
29 Jan 2020 7:00 am
RNS
Half Year Results 2019-20

a d v e r t i s e m e n t